Spyre Therapeutics (SYRE) Asset Utilization Ratio (2017 - 2024)
Spyre Therapeutics' (SYRE) Asset Utilization Ratio came in at 0.00 for Q1 2024, down 91.2% from 0.02 a year earlier and down 48.6% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Asset Utilization Ratio (2017 - 2024) Analysis & Trends
Since Q4 2017, Spyre Therapeutics has reported Asset Utilization Ratio for 18 quarters.
- In prior years, Spyre Therapeutics' Asset Utilization Ratio was 0.03 in FY2022 (-81.4%) and 0.14 in FY2021.
- The Q1 2024 figure stands as the lowest quarterly Asset Utilization Ratio in data going back to Q4 2017.
- On a year-over-year basis, Asset Utilization Ratio has declined in each of the last eight quarters, with an average decline of 74.5% over the last eight quarters.
- The year-over-year decline in Asset Utilization Ratio has ranged between 16.0% (Q2 2022) and 92.0% (Q3 2023) over the last five years.
- According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 0.00 (Q4 2023), 0.00 (Q3 2023) and 0.01 (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 0.47 |
| 10 | Spyre Therapeutics | 7.84 Bn | 7.84 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.03 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.07 |
| Mar 31, 2022 | 0.21 |
| Dec 31, 2021 | 0.16 |
| Sep 30, 2021 | 0.11 |
| Jun 30, 2021 | 0.09 |
| Mar 31, 2019 | 0.02 |
| Dec 31, 2018 | 0.05 |
| Sep 30, 2018 | 0.07 |
| Jun 30, 2018 | 0.10 |
| Mar 31, 2018 | 0.11 |
| Dec 31, 2017 | 0.09 |
API Access
Spyre Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();